Efficient Production of a Novel Subtilisin-like Serine Protease in for the Preparation of DPP-IV Inhibitory Activity Peptides from Protein Byproducts.

J Agric Food Chem

Key Laboratory of Food Bioengineering (China National Light Industry), College of Food Science & Nutritional Engineering, China Agricultural University, Beijing 100083, China.

Published: September 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Proteases play a crucial role in the bioconversion of proteins into bioactive peptides. is an important cell factory for enzyme production due to its strong post-translational modification capabilities and excellent protein secretion system. In this study, a novel subtilisin-like serine protease (S8) from was efficiently expressed extracellularly in FBL-B for the first time using a polycistronic system and the coexpression strategy of the gene (hemoglobin from ). The recombinant FBL-B produced a high protease activity of up to 5250.5 U/mL with a protein concentration of 6.5 g/L through fed-batch fermentation in a 5 L fermenter. The purified S8 showed optimal activity at pH 10.0 and 50 °C. It displayed broad substrate specificity and a high specific activity of 1578.5 U/mg toward casein. Furthermore, S8 efficiently hydrolyzed nine industrial protein byproducts to produce valuable dipeptidyl peptidase IV (DPP-IV) inhibitory activity peptides. Among them, the walnut meal and whey protein hydrolysates exhibited higher DPP-IV inhibitory activity, with IC values of 3.24 and 3.53 mg/mL, respectively. This study provides valuable strategies for the efficient production of foreign enzymes in and the high-value utilization of protein byproducts.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jafc.5c06047DOI Listing

Publication Analysis

Top Keywords

dpp-iv inhibitory
12
inhibitory activity
12
protein byproducts
12
efficient production
8
novel subtilisin-like
8
subtilisin-like serine
8
serine protease
8
activity peptides
8
activity
6
protein
6

Similar Publications

Dipeptidyl-peptidase (DPP)-IV inhibition by penultimate N-terminus Pro-containing peptides is a promising strategy for Type 2 diabetes (T2D) management, as it prevents the degradation of incretin hormones (DPP-IV substrates) like glucagon-like peptide-1 (GLP-1), thereby prolonging their half-life. However, the stability and bio-accessibility of these peptides are crucial to their efficacy in orally administered therapeutics. We previously identified LPCL and TPFLPDE peptides from tilapia viscera by-products hydrolysates, which exhibited significant DPP-IV inhibition in vitro and in situ while effectively preserving active GLP-1 levels after 2 h treatment in STC-1 cells under basal glucose conditions.

View Article and Find Full Text PDF

Essential amino acid (EAA) supplementation is often employed in sportive and clinical nutrition due to EAAs' role in muscle mass maintenance and growth. EAAs are also involved in insulin and glucagone regulation in diabetes management, but only few reports investigate their possible implication as dipeptidyl peptidase-IV (DPP-IV) inhibitors and their effect on the stability and secretion of enteroendocrine hormones. A blend of EAAs (called GAF) available as a food supplement, in a specific qualitative and quantitative ratio, was investigated to address its in vitro bioaccessibility, its hypoglycemic properties in vitro and in situ on cellular models, and its safety on intestinal Caco-2 cells.

View Article and Find Full Text PDF

Bioactivities Derived from Dry-Cured Ham Peptides: A Review.

Antioxidants (Basel)

August 2025

Faculty of Pharmacy and Nutrition, Universidad Católica de Murcia-UCAM, Campus de los Jerónimos, 30107 Murcia, Spain.

Dry-cured ham is a traditional food in the Mediterranean diet, which, in addition to its sensory qualities, is a natural source of bioactive peptides generated during the curing process through the action of endogenous enzymes on muscle and sarcoplasmic proteins. These low-molecular-weight peptides have attracted growing interest due to their multiple bioactivities, including antihypertensive, antioxidant, antimicrobial, antidiabetic, and anti-inflammatory effects described in vitro, in vivo, and in preliminary human studies. The identification of specific sequences, such as AAPLAP, KPVAAP, and KAAAAP (ACE inhibitors), SNAAC and GKFNV (antioxidants), RHGYM (antimicrobial), and AEEEYPDL and LGVGG (dipeptidyl peptidase-IV and α-glucosidase inhibitors), has been possible thanks to the use of peptidomics techniques, tandem mass spectrometry, and bioinformatics tools that allow their activity to be characterized, their digestive stability to be predicted, and their bioavailability to be evaluated.

View Article and Find Full Text PDF

Background: KALVAP is an angiotensin-converting enzyme inhibitor derived from Ziziphus jujuba, but shows poor dipeptidyl peptidase (DPP)-IV inhibitory activity. To remedy this shortcoming, KALVAP was modified according to the distinctive features of DPP-IV inhibitory peptides, yielding nine novel peptides. The DPP-IV inhibitory activity of the peptides was further verified in vitro and in vivo.

View Article and Find Full Text PDF

Sennoside A from Cassia angustifolia as a mixed-type inhibitor of DPP-IV: Integrative in vitro, in silico, and kinetic characterization.

Biochem Biophys Res Commun

August 2025

Redox Regulation Laboratory, Department of Zoology, College of Basic Science and Humanities, Odisha University of Agriculture and Technology, Bhubaneswar, 751003, India. Electronic address:

Type 2 diabetes mellitus represents a growing global health crisis, with India alone projected to surpass 124 million cases by 2040. Its multifactorial pathophysiology-including oxidative stress, insulin resistance, β-cell dysfunction, and impaired incretin signaling-is often inadequately addressed by existing therapies, which may lose efficacy and cause side effects over time. This highlights the need for safer, multi-targeted agents from natural sources.

View Article and Find Full Text PDF